Inspire Medical Systems, Inc. (INSP) — Analysis Summary
Inspire Medical Systems, Inc. (INSP) has a market cap of $1.76B with year-over-year revenue growth of +13.6%. Net margin stands at 15.9%. The stock trades at a P/E ratio of 13.0.
Key Takeaways
- Revenue changed +13.6% year-over-year
- Net margin of 15.9%
- P/E ratio of 13.0
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, INSP posted revenue growth of +13.6% and trades at a P/E of 13.0.
Inspire Medical Systems, Inc. (INSP)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
1,333
Headquarters
GOLDEN VALLEY, MN
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.